
CM-272
CAS No. 1846570-31-7
CM-272 ( CM272 | CM 272 )
产品货号. M12852 CAS No. 1846570-31-7
CM-272 (CM272) 是一种新型有效、选择性和可逆的 G9a/DNMT 双重抑制剂,对 G9a 和 DNMT1 的 IC50 分别为 8 nM 和 382 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1320 | 有现货 |
![]() ![]() |
10MG | ¥2341 | 有现货 |
![]() ![]() |
25MG | ¥4358 | 有现货 |
![]() ![]() |
50MG | ¥6294 | 有现货 |
![]() ![]() |
100MG | ¥8829 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称CM-272
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述CM-272 (CM272) 是一种新型有效、选择性和可逆的 G9a/DNMT 双重抑制剂,对 G9a 和 DNMT1 的 IC50 分别为 8 nM 和 382 nM。
-
产品描述CM-272 (CM272)?is a novel potent, selective and reversible dual inhibitor of G9a/DNMTs with IC50 of 8 nM and 382 nM for G9a and DNMT1, respectively; also inhibits DNMT3A/3B/GLP with IC50 of 85/1,200/2 nM, respectively; inhibits cell proliferation and promotes apoptosis in different haematological neoplasias (AML, ALL and DLBCL); significantly prolongs survival of AML, ALL and DLBCL xenogeneic models.
-
体外实验Cell Proliferation AssayCell Line:CEMO-1, MV4-11 and OCI-Ly10 cell linesConcentration:125 nM, 250 nM, 500 nM (CEMO-1 cells); 135 nM, 270 nM, 540 nM (MV4-11 cells); 100 nM, 400 nM, 1000 nM (OCI-Ly10 cells)Incubation Time:12 hours, 24 hours, 48 hours and 72?hours Result:Inhibited cell proliferation in a dose- and time-dependent manner.Cell Cycle Analysis Cell Line:CEMO-1, MV4-11 and OCI-Ly10 cell lines Concentration:125 nM, 250 nM, 500 nM (CEMO-1 cells); 135 nM, 270 nM, 540 nM (MV4-11 cells); 100 nM, 400 nM, 1000 nM (OCI-Ly10 cells)Incubation Time:24 hours Result:Blocked cell cycle progression.Apoptosis Analysis Cell Line:CEMO-1, MV4-11 and OCI-Ly10 cell lines Concentration:125 nM, 250 nM, 500 nM (CEMO-1 cells); 135 nM, 270 nM, 540 nM (MV4-11 cells); 100 nM, 400 nM, 1000 nM (OCI-Ly10 cells)Incubation Time:12 hours, 24 hours, 48 hours and 72?hours Result:Induced apoptosis in ALL, AML and DLBCL cell lines in a dose- and time-dependent manner.
-
体内实验Animal Model:Female BALB/Ca-Rag2?/?γc?/? mice (6–8-week-old) with CEMO-1 cells Dosage:2.5 mg/kg Administration:Intravenous injection; daily; for 28 days Result:Induced a statistically significant increase in overall survival (OS) in mice.
-
同义词CM272 | CM 272
-
通路Chromatin/Epigenetic
-
靶点HMTase
-
受体HMTase
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number1846570-31-7
-
分子量478.637
-
分子式C28H38N4O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 125 mg/mL (261.16 mM)
-
SMILESCC1=CC=C(O1)C2=NC3=CC(=C(C=C3C(=C2)NC4CCN(CC4)C)OC)OCCCN5CCCC5
-
化学全称6-methoxy-2-(5-methylfuran-2-yl)-N-(1-methylpiperidin-4-yl)-7-(3-(pyrrolidin-1-yl)propoxy)quinolin-4-amine
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. San José-Enériz E, et al. Nat Commun. 2017 May 26;8:15424.
2.?Bárcena-Varela M, et al. Hepatology. 2018 Jul 16. doi: 10.1002/hep.30168.